Cefepime 250mg + Tazobactum 31.25mg
You Searched
₹77
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
In Bacterial infections : Asrapime T 250mg/31.25mg Injection contains two different medicines, Cefepime and Tazobactum, that work together to kill the bacteria that cause infections. Cefipime works by stopping the growth of bacteria. Tazobactum reduces resistance and enhances the activity of Cefipime against bacteria.Asrapime T 250mg/31.25mg Injection can be used to treat many different bacterial infections. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Side effects of Asrapime T Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Asrapime TDiarrhea Increased white blood cell count (eosinophils)Injection site phlebitis Skin rash Increased liver enzymes Positive Coombs test
How to use Asrapime T Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Asrapime T Injection works Asrapime T 250mg/31.25mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Asrapime T 250mg/31.25mg Injection .
Asrapime T 250mg/31.25mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Asrapime T 250mg/31.25mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Asrapime T 250mg/31.25mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Asrapime T 250mg/31.25mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Asrapime T 250mg/31.25mg Injection may be needed. Doctor consultation is advised.
Asrapime T 250mg/31.25mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Asrapime T 250mg/31.25mg Injection may not be needed in these patients. Please consult your doctor.
If a dose of Asrapime T 250mg/31.25mg Injection is missed, it's advisable to consult your doctor.
Sector 1, Parwanoo, Himachal Pradesh 173220
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.